Dr. Mitchell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Circle
Durham, NC 27710Phone+1 919-668-6688
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of North Carolina HospitalsResidency, Internal Medicine, 2005 - 2008
- University of North Carolina at Chapel Hill School of MedicineClass of 2004
Certifications & Licensure
- NC State Medical License 2005 - 2025
- MD State Medical License 2009 - 2013
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 22 citationsEarly Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.Jeremy Force, Lynn Howie, Sara Abbott, Rex C. Bentley, P. Kelly Marcom
Clinical Breast Cancer. 2018-10-01 - 7 citationsFour Conversations: A Randomized Controlled Trial of an Online, Personalized Coping and Decision Aid for Metastatic Breast Cancer Patients.Sophia K. Smith, Kelly E. Westbrook, Kristin MacDermott, Sarthya Amarasekara, Matthew R. LeBlanc
Journal of Palliative Medicine. 2020-02-20 - 17 citationsAssociation of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation.Karen Lisa Smith, Neha Verma, Amanda L Blackford, Jennifer Lehman, Kelly Westbrook
NPJ Breast Cancer. 2022-04-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: